IMC Chicago’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
IMC Chicago's NVS Position: Q3 2026 in Review
IMC Chicago sold out of Novartis (NVS) in Q3 2026, closing a stake of 9,740 shares — an estimated $1.48M sold.
IMC Chicago first reported a position in NVS in Q2 2026 and held it in 1 quarter. The position peaked at $1.53M in Q2 2026. 1,557 funds tracked by Wall St. Rank hold NVS as of Q3 2026.
- IMC Chicago reported no remaining Novartis position as of Q3 2026 after selling out during the quarter.
- IMC Chicago sold 9,740 Novartis shares in Q3 2026, an estimated $1.48M.
- IMC Chicago first reported a position in Novartis in Q2 2026 and held it in 1 quarter.
- IMC Chicago's Novartis position peaked at $1.53M in Q2 2026.
- 1,557 funds tracked by Wall St. Rank held Novartis as of Q3 2026.
Based on IMC Chicago's 13F filing for Q3 2026, filed 5 Nov 2026.